Context Capital Management’s Tevogen Bio Holdings TVGN Stock Holding History

Context Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,998	Closed	-$2.06M	–	353
2022 Q4	$2.06M	Hold	3,998	–	–	0.15%	156
2022 Q3	$2.03M	Hold	3,998	–	–	0.14%	196
2022 Q2	$2M	Hold	3,998	–	–	0.14%	200
2022 Q1	$2M	Buy	+3,998	New	+$1.99M	0.13%	220

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Context Capital Management's TVGN Position: Q1 2023 in Review

Context Capital Management sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 3,998 shares — an estimated $2.06M sold.

Context Capital Management first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $2.06M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Context Capital Management reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Context Capital Management sold 3,998 Tevogen Bio Holdings shares in Q1 2023, an estimated $2.06M.
Context Capital Management first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
Context Capital Management's Tevogen Bio Holdings position peaked at $2.06M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.